DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Provigil (Modafinil) - Adverse Event Reports - Serious Event - Vomiting

 



Index of reports > Cases resulting in a serious event (112) > Cases with Vomiting (9)

Below is the selection of adverse event reports related to Provigil (Modafinil) that includes cases resulting in a serious event where reactions include vomiting.

Adverse event in 48 year old female receiving Provigil (Modafinil)

Reported by a consumer/non-health professional from United States on 2007-10-23

Patient: 48 year old female, weighing 190.5 kg (419.1 pounds)

Adverse reactions / side effects: Choking Sensation, Pruritus, Dyskinesia, Pain, Photopsia, Oral Discomfort, Hypoaesthesia Oral, Laboratory Test Abnormal, Oral Candidiasis, Eye Disorder, LIP Exfoliation, Respiratory Rate Increased, Migraine, Dysphagia, Vomiting, Stomatitis, Nausea, Paraesthesia Oral, LIP DRY, Anaemia, Ill-Defined Disorder, Muscle Twitching, Eye Pain, Tremor, Mucosal Inflammation, Oral Pain, Visual Disturbance, Oral Disorder, Impaired Gastric Emptying, Tardive Dyskinesia, Inflammation

Adverse event resulted in: hospitalization

Suspect drug(s):
Provigil
    Dosage: qd oral
    Administration route: Oral
    Indication: Fatigue
    Start date: 2006-09-01
    End date: 2006-09-15

Risperdal
    Dosage: 3 mg qd oral
    Administration route: Oral
    Indication: Depression
    Start date: 2002-01-01
    End date: 2006-09-15

Other drugs received by patient: Effexor XR; Lithium; Prilosec / 00661201 /; Enablex; Lipitor; Triamterene; Mirapex; Potassium Chloride; Coumadin



Adverse event in 54 year old male receiving Provigil (Modafinil)

Reported by a consumer/non-health professional from United States on 2007-10-02

Patient: 54 year old male, weighing 113.6 kg (249.9 pounds)

Adverse reactions / side effects: Agitation, Confusional State, Ischaemic Cardiomyopathy, Narcolepsy, Pulmonary Hypertension, Pain, Coma, Fall, Cardiac Disorder, Speech Disorder, Dizziness, Myocardial Infarction, Cardiac Failure Congestive, Pain in JAW, Blood Pressure Increased, Vomiting, Hypotension, Encephalopathy, Coronary Artery Disease, Cardiogenic Shock, Aggression, Renal Failure, Respiratory Failure, Heart Rate Increased, Ejection Fraction Decreased, Influenza Like Illness

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Dexedrine
    Dosage: 70mg per day
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 1992-01-01

Provigil
    Dosage: 400mg per day
    Administration route: Oral
    Start date: 2006-10-01
    End date: 2007-07-01

Other drugs received by patient: Cymbalta; Gabapentin; Vytorin; Minocycline HCL



Adverse event in 30 year old female receiving Provigil (Modafinil)

Reported by a consumer/non-health professional from United States on 2007-10-01

Patient: 30 year old female

Adverse reactions / side effects: Vomiting, Cognitive Disorder, Delusion, Anxiety, Poor Quality Sleep, Injection Site Erythema, Eye Rolling, Multiple Sclerosis, Crying

Suspect drug(s):
Betaseron
    Dosage: 2 miu, every 2d
    Indication: Relapsing-Remitting Multiple Sclerosis
    Start date: 2007-08-21
    End date: 2007-09-01

Betaseron
    Dosage: 4 miu, every 2d
    Start date: 2007-09-01

Provigil
    Indication: Fatigue



Adverse event in 15 year old male receiving Provigil (Modafinil)

Reported by a physician from United States on 2007-05-31

Patient: 15 year old male

Adverse reactions / side effects: Agitation, Oral Intake Reduced, Pruritus, Blood Creatine Abnormal, Blood Urea Abnormal, Coagulopathy, Urticaria, Headache, Pyrexia, Oedema Peripheral, Acute Respiratory Distress Syndrome, Pulmonary Oedema, Cough, White Blood Cell Count Increased, Cardiac Murmur, Hypotension, Drug Rash With Eosinophilia and Systemic Symptoms, Antinuclear Antibody Positive, Pancreatitis, Neutropenia, Dermatitis Exfoliative, Petechiae, Hepatitis, Myalgia, Capillary Leak Syndrome, Weight Increased, Fatigue, Vomiting, Swelling Face, Drug Hypersensitivity, Rhinorrhoea, Heart Rate Increased, Bradycardia, Leukopenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Provigil
    Dosage: 100 mg qd oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2006-04-13
    End date: 2006-04-16

Provigil
    Dosage: 100 mg qd oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2006-04-13
    End date: 2006-04-16

Provigil
    Dosage: 200 mg qd oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2006-04-17
    End date: 2006-04-21

Provigil
    Dosage: 200 mg qd oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2006-04-17
    End date: 2006-04-21

Provigil
    Dosage: 300 mg qd oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2006-04-22
    End date: 2006-05-01

Provigil
    Dosage: 300 mg qd oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2006-04-22
    End date: 2006-05-01

Provigil
    Dosage: 400 mg qd oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2006-05-02
    End date: 2006-05-22

Provigil
    Dosage: 400 mg qd oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2006-05-02
    End date: 2006-05-22

Other drugs received by patient: Zyprexa; Luvox; Abilify



Adverse event in 56 year old female receiving Provigil (Modafinil)

Reported by a individual with unspecified qualification from United States on 2007-05-30

Patient: 56 year old female

Adverse reactions / side effects: Speech Disorder, Vomiting, Dizziness, Vertigo, Hypertension

Adverse event resulted in: hospitalization

Suspect drug(s):
Provigil
    End date: 2007-04-01

Rebif
    Dosage: 44 mcg, 3 in 1 weeks, subcutaneous
    Indication: Multiple Sclerosis
    Start date: 2006-12-11

Other drugs received by patient: Steroids (Corticosteroid Nos); Prednisone; Accupril



Adverse event in 56 year old female receiving Provigil (Modafinil)

Reported by a individual with unspecified qualification from United States on 2007-04-17

Patient: 56 year old female

Adverse reactions / side effects: Speech Disorder, Vomiting, Vertigo, Hypertension

Adverse event resulted in: hospitalization

Suspect drug(s):
Provigil
    Start date: 2004-01-01
    End date: 2007-01-01

Rebif
    Dosage: 44 mcg, 3 in 1 weeks, subcutaneous
    Indication: Multiple Sclerosis
    Start date: 2006-12-11

Other drugs received by patient: Steroids (Corticosteroid Nos); Prednisone; Accupril



Adverse event in 15 year old male receiving Provigil (Modafinil)

Reported by a physician from United States on 2007-04-04

Patient: 15 year old male

Adverse reactions / side effects: Agitation, Pruritus, Coagulopathy, Petechiae, Headache, Pyrexia, Hepatitis, Sinus Bradycardia, Capillary Leak Syndrome, Myalgia, Weight Increased, Activated Partial Thromboplastin Time Prolonged, Fatigue, Liver Function Test Abnormal, Measles, Tachypnoea, Pulmonary Oedema, Acute Respiratory Distress Syndrome, Cough, Acute Prerenal Failure, White Blood Cell Count Increased, Vomiting, Swelling Face, Cardiac Murmur, International Normalised Ratio Increased, Hypotension, Rhinorrhoea, Blood Fibrinogen Increased, Drug Rash With Eosinophilia and Systemic Symptoms, Lung Disorder, Heart Rate Increased, Pancreatitis, Feeding Disorder, Feeling Abnormal

Adverse event resulted in: hospitalization

Suspect drug(s):
Provigil
    Dosage: 100 mg qd oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2006-04-13
    End date: 2006-04-16

Provigil
    Dosage: 100 mg qd oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2006-04-13
    End date: 2006-04-16

Provigil
    Dosage: 200 mg qd oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2006-04-17
    End date: 2006-04-21

Provigil
    Dosage: 200 mg qd oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2006-04-17
    End date: 2006-04-21

Provigil
    Dosage: 300 mg qd oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2006-04-22
    End date: 2006-05-01

Provigil
    Dosage: 300 mg qd oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2006-04-22
    End date: 2006-05-01

Provigil
    Dosage: 400 mg qd oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2006-05-02
    End date: 2006-05-22

Provigil
    Dosage: 400 mg qd oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2006-05-02
    End date: 2006-05-22

Other drugs received by patient: Zyprexa; Luvox; Abilify



Adverse event in 71 year old female receiving Provigil (Modafinil)

Reported by a physician from United States on 2007-04-03

Patient: 71 year old female, weighing 72.7 kg (159.9 pounds)

Adverse reactions / side effects: Vomiting, Malaise, Blood Electrolytes Abnormal, Blood Sodium Decreased

Adverse event resulted in: hospitalization

Suspect drug(s):
Provigil (Modafinil)

Other drugs received by patient: Lexapro



Adverse event in 54 year old male receiving Provigil (Modafinil)

Reported by a consumer/non-health professional from United States on 2007-03-16

Patient: 54 year old male, weighing 113.6 kg (249.9 pounds)

Adverse reactions / side effects: Vomiting, Pain, Coma, Cardiogenic Shock, Speech Disorder, Renal Failure, Dizziness, Myocardial Infarction, Pain in JAW, Influenza Like Illness

Adverse event resulted in: hospitalization

Suspect drug(s):
Dexedrine
    Dosage: 40mg per day
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 1992-01-01

Provigil
    Dosage: 200mg per day
    Administration route: Oral
    Start date: 2006-10-01

Other drugs received by patient: Cymbalta; Gabapentin

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009